These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 16022733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neurobiology of animal models of attention-deficit hyperactivity disorder.
    Russell VA.
    J Neurosci Methods; 2007 Apr 15; 161(2):185-98. PubMed ID: 17275916
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D, Ruocco LA, Arcieri S, Sadile AG.
    Neural Plast; 2004 Apr 15; 11(1-2):133-49. PubMed ID: 15303310
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF.
    J Clin Psychiatry; 2006 Apr 15; 67 Suppl 8():7-12. PubMed ID: 16961424
    [Abstract] [Full Text] [Related]

  • 10. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychopharmacol; 2008 Jun 15; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Neurobiology of attention deficit hyperactivity disorder].
    Wankerl B, Hauser J, Makulska-Gertruda E, Reißmann A, Sontag TA, Tucha O, Lange KW.
    Fortschr Neurol Psychiatr; 2014 Jan 15; 82(1):9-29. PubMed ID: 24446115
    [Abstract] [Full Text] [Related]

  • 14. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.
    Oades RD, Sadile AG, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, Johansen EB, Ruocco LA, Russell VA.
    Dev Sci; 2005 Mar 15; 8(2):122-31. PubMed ID: 15720370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q, Lu G, Antonio GE, Mak YT, Rudd JA, Fan M, Yew DT.
    Neurochem Int; 2007 May 15; 50(6):848-57. PubMed ID: 17395336
    [Abstract] [Full Text] [Related]

  • 18. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J.
    Biol Psychiatry; 2005 Jun 01; 57(11):1215-20. PubMed ID: 15949990
    [Abstract] [Full Text] [Related]

  • 19. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J.
    J Clin Psychopharmacol; 2008 Jun 01; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [Abstract] [Full Text] [Related]

  • 20. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder.
    Misener VL, Luca P, Azeke O, Crosbie J, Waldman I, Tannock R, Roberts W, Malone M, Schachar R, Ickowicz A, Kennedy JL, Barr CL.
    Mol Psychiatry; 2004 May 01; 9(5):500-9. PubMed ID: 14569274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.